Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 41 out of 100. Risk factors

Topic: Amyloid, tau and blood-test diagnosis

Older adults with Alzheimer's disease (AD) frequently present to emergency departments (EDs) with multiple coexisting conditions. However, age-specific patterns of multimorbidity in AD-related ED encounters remain incompletely characterized. To identify and describe age-specific multimorbidity subtypes among AD-associated ED encounters using unsupervised machine learning and heatmap-based diagnostic profiling. We conducted a cross-sectional analysis of the 2022 Nationwide Emergency Department Sample. AD-associated encounters were identified by an ICD-10-CM G30.x diagnosis code in any diagnosis field. The cohort included 125,461 ED encounters and was stratified into four age groups: 60-64, 65-74, 75-84, and ≥ 85 years. For each age group, the 30 most frequent co-occurring diagnoses were converted into binary indicators. KMeans clustering with eight clusters per age group was used for heatmap-based subtyping, while Uniform Manifold Approximation and Projection and Hierarchical Density-Based Spatial Clustering of Applications with Noise were used to visualize diagnostic structure. Distinct multimorbidity profiles were identified across all age groups. Among adults aged 60-74 years, clusters commonly included psychiatric and metabolic conditions, such as depression, anxiety, diabetes, chronic kidney disease, substance-use diagnoses, and dehydration. Among adults aged ≥ 75 years, clusters more frequently included cardiorenal disease, urinary tract infection, metabolic encephalopathy, respiratory failure, do-not-resuscitate status, and palliative care. The cohort had a mean age of 81.7 ± 7.2 years, and 62.6% of encounters involved women. Patterns of coexisting conditions in AD-related ED visits differed substantially by age. Adults aged 60-74 years more often showed psychiatric and metabolic combinations, whereas those aged ≥ 75 years more often showed infection, cardiorenal disease, respiratory failure, and end-of-life care markers. Recognizing these age-related patterns may help clinicians anticipate common care needs when evaluating patients with AD in the ED.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Tursun, A., Ebrahim, T., & Van Benschoten Andrew, H. (2026). Data-driven subtyping of Alzheimer's emergency presentations using unsupervised machine learning. IBRO neuroscience reports. https://doi.org/10.1016/j.ibneur.2026.08.016

Vancouver

Tursun A, Ebrahim T, Van Benschoten Andrew H. Data-driven subtyping of Alzheimer's emergency presentations using unsupervised machine learning. IBRO neuroscience reports. 2026. doi:10.1016/j.ibneur.2026.08.016. PMID: 42698748.

BibTeX

@article{tursun2026-42698748,
  author  = {Tursun, Alkam and Ebrahim, Tarshizi and Van Benschoten Andrew, H.},
  title   = {{Data-driven subtyping of Alzheimer's emergency presentations using unsupervised machine learning}},
  journal = {IBRO neuroscience reports},
  year    = {2026},
  doi     = {10.1016/j.ibneur.2026.08.016},
  pmid    = {42698748},
  url     = {https://doi.org/10.1016/j.ibneur.2026.08.016}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This cross-sectional analysis of emergency department visits identified different patterns of coexisting conditions in people with Alzheimer's disease by age group. It describes emergency presentations and multimorbidity, not any treatment, cure, or prevention.

Study details

How this study scored 41/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 0 of 4; Study design 4 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 4 of 4; Effect reported 2 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 1 of 6; Still being cited 0 of 4; Senior author's track record 0 of 4; Institution's track record 0 of 3; Multi-centre collaboration 0 of 3; Indexed in PubMed 2 of 2; Free to read 0 of 2. Total 41 of 100.41 of 100 points earned59 not earned

Published in a peer-reviewed journal, and it is a snapshot of people at one point in time. Scored zero for randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (IBRO neuroscience reports)
Journal's citation record 0 / 4 IBRO Neuroscience Reports: journal h-index 29 (OpenAlex, 2026-10-29)
Study design 4 / 12 A snapshot of people at one point in time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 4 / 4 125,461 participants
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-17)
Citations per year 0 / 5 0.0 citations a year over 2 year(s) since 2026
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 1 / 6 Cited by 2 other studies in this library
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 0 / 4 Last-listed author Andrew H Van Benschoten: h-index 4 (OpenAlex, whole career)
Institution's track record 0 / 3 University of San Diego: institution h-index 225 (OpenAlex)
Multi-centre collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 42698748)
Free to read 0 / 2 Behind a paywall — scores zero
Total 41 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Later studies that cite this one

2 studies in the alzhub library list this one in their references.

Related studies in Risk factors

Also tagged “classification”

835 studies in the library carry the topic tag “classification”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 835 tagged studies.

Similar studies

More on Risk factors

See all studies in Risk factors →